Abstract
Introduction: Data on people living with human immunodeficiency virus (PLWH) in the current SARS-CoV-2 pandemic are still scarce. This case series of 33 PLWH patients with COVID-19 reveals symptoms and outcome in this special population. Methods Retrospective analysis of anonymized data including age, gender, HIV-associated parameters, symptoms, and outcome. Results Three out of 32 patients with documented outcomes died (9%). 91% of the patients recovered and 76% have been classified as mild cases. All patients were on antiretroviral treatment, of them 22 on tenofovir-containing regimen and 4 on the protease inhibitor darunavir. Conclusions: This preliminary case series does not support excess morbidity and mortality among symptomatic COVID-19 PLWH and with viral suppression on ART. SARS-CoV-2 infections may occur during boosted darunavir-based and/or on tenofovir-containing ART.
| Dokumententyp: | Zeitschriftenartikel | 
|---|---|
| Fakultät: | Medizin | 
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit | 
| ISSN: | 0300-8126 | 
| Sprache: | Englisch | 
| Dokumenten ID: | 85469 | 
| Datum der Veröffentlichung auf Open Access LMU: | 25. Jan. 2022 09:14 | 
| Letzte Änderungen: | 25. Jan. 2022 09:14 | 
 
		 
	 
    


